No,we need cash upfront,but putting Head and Neck or Anal in similar type hands,might bring in something because the prelim results were awesome. We need the AIM2CERV go ahead from the FDA,and then the partner that`s waiting in the wings for it to sign the deal. That`s right,,the partner waiting in the wings,,I said it. Someone showed interest if the trial was revised to get an earlier data read,IMO,and the deal will be struck after we get the green light. Some think the Amgn departure was the reason for the Cervix reversal,and I don`t,I think it was because they had a meeting with an interested party,and they said shorten the trial and the expense,and we`ll play. I know,next it`ll be said I`m in denial,and delusional,,to each his own. I don`t wish for a negative outcome for Adxs on anything,like some do,and it`s not just because of my investment. Look at all the cancer types we`re striving to have a fix for,and think about all the patients that could save. Fingers crossed always for adxs.
News 
Market Data 
Discover 
AI
